Sun Pharma, Lupin top picks: Devang Mehta

Devang Mehta of Anand Rathi Financial Services told CNBC-TV18, "We have been quite vocal about the pharma sector that the largecap pharma space, there are selective opportunities still. Though in the little bit of an expensive zone but something like Sun Pharma and Lupin still remains the top pick. However, more money has to be made in the midcap pharma space."

"We have been talking about stocks like Granules India, stocks like Suven Life Sciences and even something like Ipca Labs which had its own share of problems, all these stocks still present some upside. The valuations at which they are currently available leaves a lot of upside if you compare it to its largecap peers," he said.